Avacta presenting new Affirmer applications at San Diego convention
Avacta Group
45.30p
16:55 24/04/24
1.80%
0.80p
Developer of ‘Affirmer’ biotherapeutics and reagents, Avacta Group, announced on Tuesday that its chief technology officer, Dr Matt Johnson, would be presenting at the Annual Biomarkers & Precision Medicine Congress in San Diego, being held 9-11 October.
FTSE AIM All-Share
754.69
16:50 24/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
21,897.50
17:09 24/04/24
0.14%
31.42